{
  "abstract": "Chikungunya virus (CHIKV) is a re-emerging arbovirus that causes debilitating inflammatory arthritis, for which no approved antiviral therapy currently exists. This study investigated the potential of repurposing erlotinib, a tyrosine kinase inhibitor, as an anti-CHIKV agent. Erlotinib demonstrated promising in vitro antiviral activity, with EC50 values in the low micromolar range and a favorable selectivity index. However, in vivo evaluation in C57BL/6 mice revealed pharmacokinetic limitations, characterized by rapid absorption and clearance, resulting in insufficient drug exposure under standard dosing regimens. Escalation to an intensive four-times-daily (QID) regimen successfully maintained plasma concentrations above the in vitro therapeutic threshold but led to significant body weight loss and failed to reduce viral titers or viral RNA levels in infected tissues. However, a once-daily (OD) regimen improved tolerability and significantly reduced footpad and serum viral titers relative to vehicle-treated controls. Notably, despite the lack of virological control in the QID regimen, erlotinib treatment reduced leukocyte infiltration and tissue inflammation in both treatment regimens, indicating a host-directed immunomodulatory effect. Overall, these findings highlight the critical role of dosing frequency in determining erlotinib's in vivo antiviral efficacy against CHIKV and suggest that once-daily (OD) administration may represent a more viable dosing strategy for further evaluation of erlotinib as a host-directed antiviral against CHIKV. Future strategies should also explore combination approaches with direct-acting antivirals to achieve more viral suppression and mitigation of disease pathology, as well as Structure-Activity Relationship (SAR)-guided scaffold optimization to improve in vivo pharmacokinetic profiles.",
  "abstract_shown": true,
  "affiliations": [
    "Center of Excellence in Applied Medical Virology, Department of Microbiology, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.",
    "Medical Science Program, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.",
    "Center of Excellence in Natural Products Chemistry, Department of Chemistry, Faculty of Science, Chulalongkorn University, Bangkok, Thailand.",
    "Center of Excellence in Clinical Pharmacokinetics and Pharmacogenomics, Department of Pharmacology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.",
    "Chula Pharmacokinetic Research Center, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.",
    "Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.",
    "Pharmacometrics for Health Sciences Research Group, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand."
  ],
  "article_type": "Research Article",
  "arxiv": null,
  "author_total": 12,
  "authors": [
    {
      "affs": [
        0,
        1
      ],
      "name": "Chidinma Nelson Orji"
    },
    {
      "affs": [
        0,
        1
      ],
      "name": "Naphat Loeanurit"
    },
    {
      "affs": [
        2
      ],
      "name": "Akeanan Sroithongmoon"
    },
    {
      "affs": [
        3
      ],
      "name": "Noppadol Wacharachaisurapol"
    },
    {
      "affs": [
        4
      ],
      "name": "Yaowatree Jumroen"
    },
    {
      "affs": [
        4
      ],
      "name": "Wanna Eiamart"
    },
    {
      "affs": [
        3,
        4
      ],
      "name": "Supeecha Wittayalertpanya"
    },
    {
      "affs": [
        5,
        6
      ],
      "name": "Weerachai Chaijamorn"
    },
    {
      "affs": [
        5,
        6
      ],
      "name": "Tatta Sriboonruang"
    },
    {
      "affs": [
        5,
        6
      ],
      "name": "Jirapat Vamananda"
    },
    {
      "affs": [
        2
      ],
      "name": "Tanatorn Khotavivattana"
    },
    {
      "affs": [
        0
      ],
      "name": "Siwaporn Boonyasuppayakorn",
      "orcid": "0000-0002-3631-3573"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/2qkvm5f9j0eaa.bib",
  "cited_by": 0,
  "doi": "10.1371/journal.pone.0360169",
  "fulltext_url": "https://europepmc.org/articles/PMC13726984",
  "id": "2qkvm5f9j0eaa",
  "issns": [
    "1932-6203"
  ],
  "landing_url": "https://doi.org/10.1371/journal.pone.0360169",
  "language": "eng",
  "licence": "CC-BY",
  "licence_label": "CC BY",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Alphaviruses"
    ],
    [
      "heading",
      "Anatomy"
    ],
    [
      "heading",
      "Animal Models"
    ],
    [
      "heading",
      "Animal Studies"
    ],
    [
      "heading",
      "Antiviral Therapy"
    ],
    [
      "heading",
      "Biology and Life Sciences"
    ],
    [
      "heading",
      "Biology and life sciences"
    ],
    [
      "heading",
      "Blood"
    ],
    [
      "heading",
      "Blood Plasma"
    ],
    [
      "heading",
      "Body Fluids"
    ],
    [
      "heading",
      "Chikungunya Virus"
    ],
    [
      "heading",
      "Clinical Medicine"
    ],
    [
      "heading",
      "Experimental Organism Systems"
    ],
    [
      "heading",
      "Immune Response"
    ],
    [
      "heading",
      "Immunology"
    ],
    [
      "heading",
      "Inflammation"
    ],
    [
      "heading",
      "Medical Microbiology"
    ],
    [
      "heading",
      "Medicine and Health Sciences"
    ],
    [
      "heading",
      "Microbial Pathogens"
    ],
    [
      "heading",
      "Microbiology"
    ],
    [
      "heading",
      "Model Organisms"
    ],
    [
      "heading",
      "Mouse Models"
    ],
    [
      "heading",
      "Oral Administration"
    ],
    [
      "heading",
      "Organisms"
    ],
    [
      "heading",
      "Pathogens"
    ],
    [
      "heading",
      "Pathology and Laboratory Medicine"
    ],
    [
      "heading",
      "Pharmacokinetics"
    ],
    [
      "heading",
      "Pharmacology"
    ],
    [
      "heading",
      "Physiology"
    ],
    [
      "heading",
      "Preventive Medicine"
    ],
    [
      "heading",
      "Public and Occupational Health"
    ],
    [
      "heading",
      "RNA viruses"
    ],
    [
      "heading",
      "Research Article"
    ],
    [
      "heading",
      "Research and Analysis Methods"
    ],
    [
      "heading",
      "Routes of Administration"
    ],
    [
      "heading",
      "Signs and Symptoms"
    ],
    [
      "heading",
      "Togaviruses"
    ],
    [
      "heading",
      "Toxicity"
    ],
    [
      "heading",
      "Toxicology"
    ],
    [
      "heading",
      "Vaccination and Immunization"
    ],
    [
      "heading",
      "Viral Pathogens"
    ],
    [
      "heading",
      "Viruses"
    ],
    [
      "openalex",
      "2739|Mosquito-borne diseases and control"
    ],
    [
      "plos",
      "/Biology and life sciences/Anatomy/Body fluids/Blood/Blood plasma"
    ],
    [
      "plos",
      "/Biology and life sciences/Immunology/Immune response/Inflammation"
    ],
    [
      "plos",
      "/Biology and life sciences/Immunology/Vaccination and immunization/Antiviral therapy"
    ],
    [
      "plos",
      "/Biology and life sciences/Microbiology/Medical microbiology/Microbial pathogens/Viral pathogens/Togaviruses/Alphaviruses/Chikungunya virus"
    ],
    [
      "plos",
      "/Biology and life sciences/Organisms/Viruses/RNA viruses/Togaviruses/Alphaviruses/Chikungunya virus"
    ],
    [
      "plos",
      "/Biology and life sciences/Organisms/Viruses/Viral pathogens/Togaviruses/Alphaviruses/Chikungunya virus"
    ],
    [
      "plos",
      "/Biology and life sciences/Physiology/Body fluids/Blood/Blood plasma"
    ],
    [
      "plos",
      "/Biology and life sciences/Toxicology/Toxicity"
    ],
    [
      "plos",
      "/Medicine and health sciences/Anatomy/Body fluids/Blood/Blood plasma"
    ],
    [
      "plos",
      "/Medicine and health sciences/Clinical medicine/Signs and symptoms/Inflammation"
    ],
    [
      "plos",
      "/Medicine and health sciences/Immunology/Immune response/Inflammation"
    ],
    [
      "plos",
      "/Medicine and health sciences/Immunology/Vaccination and immunization/Antiviral therapy"
    ],
    [
      "plos",
      "/Medicine and health sciences/Pathology and laboratory medicine/Pathogens/Microbial pathogens/Viral pathogens/Togaviruses/Alphaviruses/Chikungunya virus"
    ],
    [
      "plos",
      "/Medicine and health sciences/Pathology and laboratory medicine/Toxicology/Toxicity"
    ],
    [
      "plos",
      "/Medicine and health sciences/Pharmacology/Pharmacokinetics"
    ],
    [
      "plos",
      "/Medicine and health sciences/Pharmacology/Routes of administration/Oral administration"
    ],
    [
      "plos",
      "/Medicine and health sciences/Public and occupational health/Preventive medicine/Vaccination and immunization/Antiviral therapy"
    ],
    [
      "plos",
      "/Research and analysis methods/Animal studies/Experimental organism systems/Animal models/Mouse models"
    ],
    [
      "plos",
      "/Research and analysis methods/Animal studies/Experimental organism systems/Model organisms/Mouse models"
    ],
    [
      "plos",
      "/Research and analysis methods/Model organisms/Mouse models"
    ]
  ],
  "openalex": "W7225129843",
  "pdf_url": "https://europepmc.org/articles/PMC13726984?pdf=render",
  "pmcid": "PMC13726984",
  "pmid": "42970557",
  "published": "2026-11-02",
  "publisher": "Public Library of Science",
  "ris": "https://research.draconitic.com/paper/2qkvm5f9j0eaa.ris",
  "sources": [
    {
      "first_seen": "2026-11-03T12:20:16Z",
      "native_id": "10.1371/journal.pone.0360169",
      "source": "plos",
      "url": "https://doi.org/10.1371/journal.pone.0360169"
    },
    {
      "first_seen": "2026-11-04T15:20:43Z",
      "native_id": "MED:42970557",
      "source": "europepmc",
      "url": "https://europepmc.org/article/MED/42970557"
    },
    {
      "first_seen": "2026-11-05T12:23:12Z",
      "native_id": "PMC13726984",
      "source": "pmc",
      "url": "https://doi.org/10.1371/journal.pone.0360169"
    }
  ],
  "subjects": [
    {
      "field": "biology",
      "origin": "plos:immunology",
      "subfield": "immunology"
    },
    {
      "field": "biology",
      "origin": "heading:Microbiology",
      "subfield": "microbiology"
    },
    {
      "field": "medicine",
      "origin": "heading:Public and Occupational Health",
      "subfield": "epidemiology-public-health"
    },
    {
      "field": "medicine",
      "origin": "plos:toxicology",
      "subfield": "pharmacology-toxicology"
    },
    {
      "field": "medicine",
      "origin": "plos:anatomy",
      "subfield": "physiology"
    }
  ],
  "title": "Erlotinib in a once-daily high-dose oral regimen could mitigate Chikungunya virus titer in mice",
  "title_text": "Erlotinib in a once-daily high-dose oral regimen could mitigate Chikungunya virus titer in mice",
  "type": "peer-reviewed",
  "updated_at": "2026-11-06T12:22:48Z",
  "url": "https://research.draconitic.com/paper/2qkvm5f9j0eaa",
  "venue": "PLOS One",
  "versions": []
}